Now just emerging from a year of legal and financial blows and bad publicity, SFBC has decided to change its name to PharmaNet Development Group, pending shareholder approval later this month.
Quintiles Creates Strategic Biostatistics Unit
Raleigh, N.C.-based Quintiles has created a statistical working group called the Strategic Biostatistics Unit, which provides guidance to clients on using advanced statistical methods to adjust such variables as the number of patients, trial length, dosing arms and including safety and efficacy endpoints. Applying such methods to protocol design early can offer sponsors significant cost and time savings without statistically invalidating trial data. In addition, the unit’s expertise can develop adaptive clinical trial designs.
